Guidelines for treatment of candidiasis

被引:955
作者
Pappas, PG
Rex, JH
Sobel, JD
Filler, SG
Dismukes, WE
Walsh, TJ
Edwards, JE
机构
[1] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA
[2] AstraZeneca, Manchester, Lancs, England
[3] Wayne State Univ, Sch Med, Detroit, MI USA
[4] Harbor Univ Calif Los Angeles Med Ctr, Torrance, CA USA
[5] NCI, Immunocompromised Host Sect, Pediat Oncol Branch, Bethesda, MD 20892 USA
关键词
D O I
10.1086/380796
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Candida species are the most common cause of fungal infections. Candida species produce infections that range from non-life-threatening mucocutaneous illnesses to invasive processes that may involve virtually any organ. Such a broad range of infections requires an equally broad range of diagnostic and therapeutic strategies. These guidelines summarize current knowledge about treatment of multiple forms of candidiasis for the Infectious Diseases Society of America (IDSA). Throughout this document, treatment recommendations are rated according to the standard scoring scheme used in other IDSA guidelines to illustrate the strength of the supporting evidence and quality of the underlying data ( table 1). This document covers the following 4 major topical areas.
引用
收藏
页码:161 / 189
页数:29
相关论文
共 346 条
  • [1] AMPHOTERICIN-B IN THE TREATMENT OF CANDIDA CHOLECYSTITIS
    ADAMSON, PC
    RINALDI, MG
    PIZZO, PA
    WALSH, TJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1989, 8 (06) : 408 - 411
  • [2] CLINICAL AND MYCOLOGICAL EVALUATION OF FLUCONAZOLE IN THE SECONDARY PROPHYLAXIS OF ESOPHAGEAL CANDIDIASIS IN AIDS PATIENTS - AN OPEN, MULTICENTER STUDY
    AGRESTI, MG
    DEBERNARDIS, F
    MONDELLO, F
    BELLOCCO, R
    CAROSI, GP
    CAPUTO, RM
    MILAZZO, F
    CHIODO, F
    GIANNINI, V
    MINOLI, L
    ORTONA, L
    PASTORE, G
    PIAZZA, M
    SCALISE, G
    CIRELLI, A
    CHIESI, A
    GRECO, D
    VELLA, S
    CASSONE, A
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1994, 10 (01) : 17 - 22
  • [3] Agustin J, 1999, CLIN INFECT DIS, V29, P686, DOI 10.1086/598658
  • [4] USE OF FLUCONAZOLE IN THE TREATMENT OF CANDIDAL ENDOPHTHALMITIS
    AKLER, ME
    VELLEND, H
    MCNEELY, DM
    WALMSLEY, SL
    GOLD, WL
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) : 657 - 664
  • [5] A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients
    Ally, R
    Schürmann, D
    Kreisel, W
    Carosi, G
    Aguirrebengoa, K
    Dupont, B
    Hodges, M
    Troke, P
    Romero, AJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (09) : 1447 - 1454
  • [6] ALMEKINDERS LC, 1991, CLIN ORTHOP RELAT R, P174
  • [7] NIPPLE PAIN, MASTALGIA AND CANDIDIASIS IN THE LACTATING BREAST
    AMIR, LH
    PAKULA, S
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1991, 31 (04) : 378 - 380
  • [8] Candida albicans: Is it associated with nipple pain in lactating women?
    Amir, LH
    Garland, SM
    Dennerstein, L
    Farish, SJ
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1996, 41 (01) : 30 - 34
  • [9] FLUCONAZOLE THERAPY FOR CHRONIC DISSEMINATED CANDIDIASIS IN PATIENTS WITH LEUKEMIA AND PRIOR AMPHOTERICIN-B THERAPY
    ANAISSIE, E
    BODEY, GP
    KANTARJIAN, H
    DAVID, C
    BARNETT, K
    BOW, E
    DEFELICE, R
    DOWNS, N
    FILE, T
    KARAM, G
    POTTS, D
    SHELTON, M
    SUGAR, A
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (02) : 142 - 150
  • [10] Anaissie E, 1995, 35 INT C ANT AG CHEM